Fairfield Financial Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$850K Sell
1,796
-28
-2% -$14.1K 0.29% 45
2025
Q4
$851K Buy
1,824
+322
+21% +$149K 0.28% 45
2025
Q3
$640K Buy
1,502
+401
+36% +$155K 0.22% 50
2025
Q2
$422K Buy
1,101
+114
+12% +$41.1K 0.15% 57
2025
Q1
$341K Sell
987
-569
-37% -$183K 0.13% 55
2024
Q4
$467K Sell
1,556
-128
-8% -$44.7K 0.16% 51
2024
Q3
$685K Buy
1,684
+126
+8% +$46.1K 0.23% 47
2024
Q2
$500K Buy
+1,558
New +$506K 0.15% 50
2023
Q4
$376K Buy
1,389
+522
+60% +$129K 0.14% 54
2023
Q3
$213K Buy
+867
New +$237K 0.09% 63

Other funds holding HCA

Fairfield Financial Advisors's HCA Position: Q1 2026 in Review

Fairfield Financial Advisors reduced its HCA Healthcare (HCA) stake by 1.5% in Q1 2026, selling an estimated $14.1K and leaving 1,796 shares worth $850K. The position accounts for 0.29% of the portfolio, ranked #45.

Fairfield Financial Advisors first reported a position in HCA in Q3 2023 and has held it in 10 quarters since. The position peaked at $851K in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Fairfield Financial Advisors held 1,796 shares of HCA Healthcare worth $850K as of Q1 2026.
  • Fairfield Financial Advisors sold 28 HCA Healthcare shares in Q1 2026, an estimated $14.1K.
  • HCA Healthcare made up 0.29% of Fairfield Financial Advisors's portfolio in Q1 2026, its #45 holding.
  • Fairfield Financial Advisors first reported a position in HCA Healthcare in Q3 2023 and has held it in 10 quarters since.
  • Fairfield Financial Advisors's HCA Healthcare position peaked at $851K in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Fairfield Financial Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.